FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma
1. 系统已在2025-05-16 11:40:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.ccr-24-3439
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Sonia Singh; Diana Bradford; Somak Chatterjee; Xiaoxue Li; Stephanie L. Aungst; Amy M. Skinner; Claudia P. Miller; Sarah Kim-McOlash; Jeanne Fourie Zirkelbach; Ye Xiong; Youwei Bi; Ying-Hong Wang; Yuching Yang; Jielin Sun; Jeffrey Kraft; Rosane Charlab; Stacy S. Shord; Shenghui Tang; Barbara Scepura; Ilynn Bulatao; Opeyemi Udoka; Haleh Saber; Nam Atiqur Rahman; Richard Pazdur; Harpreet Singh; Martha Donoghue; Nicole Drezner
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-3439/3533147/ccr-24-3439.pdf